(Q45111052)

9 December 2017

title

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease (English)

1 reference

9 December 2017

Ho VT

1

1 reference

9 December 2017

Kim HT

2

1 reference

9 December 2017

Li S

3

1 reference

9 December 2017

Hochberg EP

4

1 reference

9 December 2017

Cutler C

5

1 reference

9 December 2017

Lee SJ

6

1 reference

9 December 2017

Fisher DC

7

1 reference

9 December 2017

Milford E

8

1 reference

9 December 2017

Kao G

9

1 reference

9 December 2017

Daley H

10

1 reference

9 December 2017

Levin J

11

1 reference

9 December 2017

Ng A

12

1 reference

9 December 2017

Mauch P

13

1 reference

9 December 2017

Alyea EP

14

1 reference

9 December 2017

Antin JH

15

1 reference

9 December 2017

Soiffer RJ

16

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Bone Marrow Transplantation

9 December 2017

published in

1 reference

9 December 2017

volume

34

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

987-994

1 reference

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

inferred from DOI database lookup

7 January 2021

based on heuristic

Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

inferred from DOI database lookup

7 January 2021

based on heuristic

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704690

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1704690

1 reference

Dimensions Publication ID

9 December 2017

1011833213

0 references

1 reference